9 results
8-K
EX-99.1
RGEN
Repligen Corp.
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
and pharmaceutical markets.
At Repligen, Mr. Loeillot will oversee all business units as well as the commercial organization, driving the commercial and corporate
8-K
EX-99.1
RGEN
Repligen Corp.
9 Jun 10
Vice President, Market Development
12:00am
hired to oversee analysis of the Phase 3 data. A successful re-read of the Phase 3 data may support registration of RG1068 for MRI imaging
8-K
EX-99.1
RGEN
Repligen Corp.
16 Apr 10
Results of Operations and Financial Condition
12:00am
with the analysis of the radiographic images by the contract research organization (CRO) hired to oversee analysis of the Phase 3 trial data. We also
8-K
EX-99.1
f4x7jfqy ehe1ah1hz
31 Jul 03
Current report
12:00am
10-K
EX-10.39
hlyqc2z0h7
17 Jul 95
Annual report
12:00am
- Prev
- 1
- Next